SameerBansilalMD, MS, FACC

Non-Invasive Cardiology, Preventive Cardiology

Attending Physician, James J. Peters Department of Veterans Affairs Medical Center

Dr. Bansilal is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Cardiovascular Disease, 2007 - 2011
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 2002 - 2005
Seth G.S. Medical CollegeClass of 2001

PubMed

11 citations
Modifiability of Composite Cardiovascular Risk Associated With Chronic Kidney Disease in Type 2 Diabetes With Finerenone.
Rajiv Agarwal, Bertram Pitt, Peter Rossing, Stefan D Anker, Gerasimos Filippatos
JAMA Cardiology. 2023-08-01
13 citations
Patient selection for long-term secondary prevention with ticagrelor: insights from PEGASUS-TIMI 54.
Marc P Bonaca, KyungAh Im, Giulia Magnani, Sameer Bansilal, Mikael Dellborg
European Heart Journal. 2022-12-21
7 citations
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
Raymond L. Benza, Athénaïs Boucly, Harrison W. Farber, Adaani E. Frost, Hossein Ardeschir Ghofrani
The Journal of Heart and Lung Transplantation. 2021-10-28

Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients with Multivessel Coronary DiseaseJanuary 2018

Bayer’s KERENDIA® (Finerenone) Receives Updated Label to Include Findings from Phase III FIGARO-DKD Cardiovascular Outcomes Study in Patients with Chronic Kidney Disease and Type 2 DiabetesSeptember 1st, 2022
Bayer’s KERENDIA® (Finerenone) Receives New Recommendations from American Diabetes Association for Improving Cardiovascular Outcomes and Managing Patients with Chronic Kidney Disease Associated with Type 2 DiabetesJune 28th, 2022
Bayer Doles Out $1M of Its PHAB Awards to 7 Research ProjectsSeptember 13th, 2021
Join now to see all